Urology Patient No-Show Rates: Benchmarks and Backfill (2026)

Urology patient no-show rates in the best published practice-level data run 9.0% overall, 11.4% for new visits, 10.5% for follow-up visits, and 3.4% for procedure visits, with oncology patients missing 4.5% of appointments and benign urology patients 9.6%. Nationally, MGMA polling shows no-show rates rising or holding flat for most medical groups every year from 2024 through 2026, with a 19.95% cancellation rate and barely a quarter of cancellations rescheduled within 30 days. For a urology group the number that matters is not the office rate but the procedure rate, because one missed lithotripsy, cystoscopy, or biopsy slot costs more than a week of missed follow-ups.

This guide covers the verified urology no-show benchmarks, why procedure no-shows are the expensive ones, the national trend, and a seven-step program to reduce no-shows and backfill the rest.

Key Takeaways

• Across 83,983 urology appointments, 9.0% were missed; new visits were missed 11.4% of the time and procedure visits only 3.4%.
• A missed appointment in the prior year raised the odds of another no-show by a factor of 2.47, and each additional week of scheduling lead time raised the odds further.
• Medicaid patients in that practice missed 17.2% of appointments, the highest of any payer group.
• MGMA polling found 32% of medical groups reporting higher no-show rates in 2026, after 27% in 2025 and 37% in 2024, despite widespread automated reminders.
• Only 27.40% of canceled visits were rescheduled within 30 days, which means most urology groups have a backfill problem larger than their no-show problem.

The Data Behind the Decision

The most useful urology-specific benchmark comes from a retrospective analysis of 83,983 appointments across 17 providers in an urban academic practice between 2017 and 2020, published in Urology Practice, 2021. The overall missed appointment rate was 9.0%. By patient type, oncology patients missed 4.5% of visits, benign urology patients 9.6%, and pediatric patients 13.0%. By visit type, procedure-based visits were missed 3.4% of the time, follow-up visits 10.5%, and new visits 11.4%. Telephone and video visits were missed under 3% of the time. Medicaid patients missed 17.2% of appointments. A prior missed appointment within one year raised the odds of another by a factor of 2.47, and each additional week between scheduling and the appointment raised the odds by about 1.8%.

Nationally the trend is not improving. MGMA, 2024 polling found 37% of medical groups reported higher no-show rates in 2024, 50% about the same, and only 13% lower, even as practices moved to new automated reminder platforms; only 15% used predictive analytics to manage no-shows. MGMA, 2025 found 27% of groups reported higher rates that year, 60% about the same, and 13% lower. MGMA, 2026 found 32% reported higher rates year to date, up five points from 2025, and cited a 19.95% appointment cancellation rate in the 2024 single-specialty aggregate with only 27.40% of canceled visits rescheduled within 30 days; 42% of practices now charge a no-show fee. Because 82% of patients try to book care outside a practice's regular office hours, the rebooking that does happen mostly happens when the front desk is closed.

Why are procedure no-shows the expensive ones in urology?

The published procedure no-show rate of 3.4% looks reassuring until you price the slot. A cystoscopy, a prostate biopsy, a lithotripsy session, or a BPH procedure at your ASC ties up a room, a nurse, equipment, and often anesthesia. When the patient does not arrive, none of that is recoverable unless another prepared patient is waiting. An office no-show costs one exam room for 16 minutes; a procedure no-show costs the block.

Procedure patients also carry the highest downstream value. The missed biopsy delays a diagnosis. The missed BPH procedure sends the patient back to medication, and often into the population that never rebooks. In urology the no-show program should be built backward from the procedure schedule, with the tightest confirmation and the readiest backfill list reserved for those slots.

What actually drives no-shows in a urology practice?

The Urology Practice data point to three drivers a practice can act on. History: the patient who missed once is 2.47 times as likely to miss again, so the program should target a known list, not every patient equally. Lead time: every week between booking and visit raises the odds, and groups with long new-patient waits are manufacturing no-shows. Visit type: new patients and benign follow-ups miss at two to three times the procedure rate, and those visits get the least confirmation effort.

Reminders alone do not close the gap; the MGMA data show that clearly. Our article on whether appointment reminders reduce no-shows covers the evidence. What works is a two-way conversation that lets the patient reschedule instead of vanishing, and a system that reaches the prior no-show patient earlier and more often than the rest. For cross-specialty context, see our average no-show rate and cost benchmarks and the orthopedic no-show rates companion article.

How should a urology practice backfill a no-show or cancellation?

Backfill is where the money is recovered, and it depends on knowing who is waiting. A urology group always has patients whose visit is due and unbooked: the surveillance PSA that opened this month, the stone patient whose imaging was never scheduled, the BPH patient whose reassessment lapsed, the referral that came in Tuesday and has not been reached. When a slot opens, software that already tracks those patients can offer it to the best-matched one by text within minutes, syncing to Epic, athenahealth, ModMed, NextGen, or meridianEMR so the front desk sees the fill.

A canceled slot offered within the hour to a patient who already needs it fills far more often than one posted to a general waitlist. That requires a continuously maintained list of overdue and unscheduled patients, which a recall system produces as a byproduct. Our guide to reducing patient no-show rates covers the general playbook.

How to Reduce No-Shows and Backfill Slots in a Urology Practice: 7 Steps

1. Measure by visit type and payer. Pull twelve months of no-shows split by new, follow-up, and procedure visits and by payer. The procedure line is the one to fix first.
2. Flag the prior no-show list. Every patient with a missed visit in the past year gets earlier and more frequent confirmation, by text and phone.
3. Shorten lead time for new patients. Protect near-term slots for referrals; a new patient booked eight weeks out is a likely no-show.
4. Confirm procedures in a two-way thread. Prep instructions, transport, and anesthesia questions answered in the same conversation, with an easy reschedule path.
5. Maintain a live backfill list. Overdue surveillance, unscheduled imaging, lapsed reassessments, and unreached referrals, ranked by urgency and slot type.
6. Offer open slots automatically. When a cancellation lands, the best-matched waiting patient gets a text with the slot within minutes.
7. Chase every no-show the same day. Reach the patient, learn why, rebook, and log it. A no-show that is rebooked within 24 hours is a scheduling event, not a lost patient.

What Should Still Go to a Human?

Whether a patient who repeatedly no-shows a biopsy should be called by the physician, whether a procedure can safely be moved up for a backfill candidate, and whether a no-show fee should be waived are judgment calls for your team. Billing disputes go to the business office. Any patient who explains a no-show with a symptom, such as pain, fever, or retention, should reach a nurse immediately with the thread attached. Software finds, reaches, and rebooks; your staff decide the exceptions.

Where Clinekt Fits

Clinekt is the patient activation platform for specialty practices: four AI agents that share one memory of every patient and cover the whole journey, from first click to the care between visits. No-shows sit at the intersection of two agents. The Inbound Agent answers the patient who wants to reschedule at 9 p.m. and books them, instead of letting the slot go silent. The Recall Agent continuously scans your records for overdue follow-ups, surveillance intervals that opened, and ordered-but-never-scheduled visits, which is exactly the list a backfill needs, and reaches those patients in one two-way thread, books them into open slots, and reports found, reached, booked, and seen. It is live the same day, with no IT project and no new staff workflow, syncs to your EHR, and is HIPAA compliant and SOC 2 Type II.

Tools that only send reminders stop at the confirmation. Clinekt keeps the conversation open, so the no-show is reached the same day and the open slot goes to a patient who needs it. The Care Management Agent runs monthly check-ins between visits, and the Outbound Agent proves what every channel produced, click to procedure. The proof point we can share is orthopedic: Baldwin Bone & Joint generated 263 qualified surgical leads and 159 booked appointments, a 60% booking rate, in a single quarter. The mechanism, a two-way thread that ends in a booked slot, is what fills a urology procedure block. More than one million patient interactions have been completed across the platform. See our urology page and the Recall Agent.

Estimate what your procedure no-shows and unfilled cancellations are worth with the leakage calculator, or book a demo to see the backfill list your EHR already contains.

Frequently Asked Questions

What is a typical no-show rate for a urology practice?
The best published urology-specific benchmark is 9.0% across 83,983 appointments in an urban academic practice, with new visits at 11.4%, follow-ups at 10.5%, and procedure visits at 3.4%. A private group in a suburban market will usually run lower than the academic figure, but the pattern by visit type holds.

Why do procedure visits have lower no-show rates than office visits in urology?
Procedure visits require preparation, often involve a pre-procedure call, and carry a clear reason the patient understands. The published 3.4% rate reflects that. The problem is that a procedure no-show costs many times what an office no-show costs, so even a low rate matters.

Do appointment reminders fix urology no-shows?
They help, but MGMA polling shows no-show rates rose or stayed flat for most groups every year from 2024 to 2026 despite near-universal automated reminders. Reminders reach the patient who was going to come anyway. The patient with a prior no-show and a long lead time needs a two-way conversation and, when they cancel, a system that backfills the slot.

What is backfill and how does it work in a urology practice?
Backfill is filling a canceled or no-showed slot with a patient who is already waiting: a surveillance PSA visit that is due, a stone follow-up that was never booked, a referral that has not been scheduled. Software that already knows who is overdue can offer the slot the moment it opens.

Does Clinekt work with Epic, athenahealth, ModMed, NextGen, and meridianEMR?
Clinekt syncs with the systems urology groups already run, including those platforms. Confirmations, rebookings, and backfilled appointments land in your existing template with no new staff workflow.

Every empty procedure slot has a patient who could have filled it. Put your no-show and cancellation numbers into the leakage calculator, then schedule a demo and we will show you the backfill in action.